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Abstract  
Much of the research on visual hallucinations (VH) has been conducted in the context of eye disease 
and neurodegenerative conditions, but little is known about these phenomena in psychiatric and non-
clinical populations. The purpose of this paper is to bring together current knowledge regarding VH 
in the psychosis phenotype, and contrast this data with the literature drawn from neurodegenerative 
disorders and eye disease. The evidence challenges the traditional views that VH are atypical or 
uncommon in psychosis. The weighted mean for VH is 27% in schizophrenia, 15% in affective 
psychosis, and 7.3% in the general community. VH are linked to a more severe psychopathological 
profile and less favourable outcome in psychosis and neurodegenerative conditions. VH typically co-
occur with auditory hallucinations suggesting a common aetiological cause. VH in psychosis are also 
remarkably complex, negative in content, and are interpreted to have personal relevance. The 
cognitive mechanisms of VH in psychosis have rarely been investigated but existing studies point to 
source-monitoring deficits and distortions in top-down mechanisms, although evidence for visual 
processing deficits which feature strongly in the organic literature is lacking. Brain imaging studies 
point to the activation of visual cortex during hallucinations on a background of structural and 
connectivity changes within wider brain networks. The relationship between VH in psychosis, eye 
disease and neurodegeneration remains unclear, although the pattern of similarities and differences 
described in this review suggests that comparative studies may have potentially important clinical 
and theoretical implications. 
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Abbreviations: 
Alzheimer’s Disease (AD) 
Charles Bonnet Syndrome (CBS) 
Cognitive Behavioural Therapy for psychosis (CBTp) 
Default-mode network (DMN) 
Diffusion Tensor Imaging (DTI) 
Hippocampal Complex (HC) 
Dementia with Lewy Bodies (DLB) 
Parkinson’s Disease (PD) 
Parkinson’s Disease Dementia (PDD) 
Visual hallucinations (VH) 
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1. Introduction 
Hallucinations are defined in different ways by different philosophical traditions
1
. In the clinical 
domain, a visual hallucination (VH) is a visual percept, experienced when awake, which is not 
elicited by an external stimulus. It contrasts with a visual illusion which is elicited by an external 
stimulus but differs from the percept normally associated with the stimulus. VH occur in a wide-
range of organic and psychiatric conditions, as well as in the absence of any demonstrable pathology. 
These experiences have been well described and researched in the context of organic disorders, 
particularly eye-disease and neurodegenerative conditions such as Dementia with Lewy Bodies 
(DLB) and Parkinson’s disease (PD), but VH have been largely neglected in psychiatric disorders 
and delirious states, and in non-clinical populations.  
Although the diagnostic manuals for mental disorders list hallucinations as a primary characteristic 
symptom in psychotic disorders, auditory hallucinations are the symptoms that clinicians commonly 
ask about. One explanation lies in the traditional beliefs that VH are more common in organic states 
than in psychosis
2
. It is also often difficult to decide whether the full criteria for the presence of VH 
have been fulfilled when a range of other perceptual abnormalities are reported. 
In this paper, we review the available evidence with regards to the prevalence, phenomenology, 
clinical characteristics and assessment methods for VH in the psychosis-spectrum alongside studies 
of cognition, brain imaging, electrophysiology and treatment (cognitive-behavioural and 
pharmacological). Given the lack of available literature on other psychiatric disorders, our focus is 
on schizophrenia, affective psychosis (i.e. bipolar and depressive disorders) and non-clinical 
population groups (who experience VH outside of the context of any psychiatric or somatic disease). 
The psychosis evidence is compared with evidence related to eye and neurodegenerative disease in 
the hope that similarities and differences between different clinical contexts will help our 
understanding of the underlying mechanisms of VH and its treatment.  
To our knowledge this is the first review of VH in psychosis. For the first time, a cross-disciplinary 
and cross-diagnostic examination of VH is also presented. Our broad aim is to provide a useful base 
for future studies on the topic, and specifically to achieve a clearer understanding of VH in 
psychiatric illness and greater clarity regarding the assessment of VH for use in clinical practice and 
research.  
Parts of this paper were presented in Durham at the 2nd International Consortium on Hallucination 
Research (ICHR) 2013 conference
3
.  
2. Epidemiology 
Psychosis 
The centrality of VH in psychosis has been put into question by studies which show that auditory, 
and not visual, hallucinations, are amongst the cardinal symptoms of schizophrenia which are 
common in all cultures
4
. VH, however, appear to be more frequent in schizophrenia than commonly 
thought.  
Table 1 describes studies that have provided the point prevalence of VH in schizophrenia. Estimates 
vary widely from 4% to 65%, reflecting variations in population and ascertainment methods. Out of 
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29 studies which have addressed this issue (5,873 participants), the weighted mean prevalence of VH 
in schizophrenia is 27% (SD = 9). For comparison, the weighted mean of auditory hallucinations as 
provided by the same studies is 59% (range: 25-86%; SD = 15), i.e. twice as frequent as VH, 
although it is possible that clinician biases towards auditory hallucinations have skewed the results. 
----Table 1--- 
Psychotic symptoms such as hallucinations and delusions are also a common feature of affective 
disorders including bipolar disorder
5
. Table 2 shows that, out of 12 studies which differentiated 
between different modalities of hallucinations, the weighted mean frequency of VH is approximately 
15% (range 6-27%, SD = 9). Similarly to schizophrenia, the rates of VH in bipolar disorder are 
approximately half that of auditory hallucinations (28%). 
Overall, these data challenge the assumption that VH are atypical or uncommon in psychosis.  
----Table 2--- 
Subclinical symptoms in the general community 
Occasional hallucinatory experiences are fairly common in community-living individuals. However, 
community and epidemiological studies rarely report the prevalence rates for VH specifically and 
independently from other hallucinatory experiences, with few exceptions. Table 3A shows that the 
weighted mean for VH in the general community is 7.3% (SD = 5, based on 6 studies). 
----Table 3 --- 
Little is known about what distinguishes visual hallucinators from non-hallucinators in the general 
population, but evidence suggests that factors such as intoxication and withdrawal from substances 
such as alcohol, cannabis and cocaine, and other physical states such as physical illness and stress are 
linked to VH
6, 7
. Importantly, when research criteria exclude hallucinations arising from drug-taking 
or physical illness, the weighted percentages of hallucinations in the community reduce to 6% (See 
Table 3B).  
Eye disease and neurodegenerative conditions  
For comparison, it is helpful to understand the epidemiology of VH in other disorders in which VH 
are common. The frequency estimates for VH in PD range from 15 to 40% (comparable to those in 
psychosis), and the frequency roughly doubles for Parkinson’s disease dementia (PDD) (30-90%) 
and DLB (60-90%)
8, 9
. In age-related eye disease, between 10% and 60% of patients experience 
complex VH, depending on the severity of visual loss. The most common eye disease associated 
with VH is age related macular degeneration
10, 11
. VH are the diagnostic criterion for Charles Bonnet 
Syndrome (CBS). Such observations have prompted many authors to suggest that VH arise because 
of dysfunctions involving visual processing. 
3. Demographic and clinical characteristics 
Gender 
Contradictory data have emerged regarding a VH gender pattern in psychosis or organic illness
12-15
. 
By contrast, studies in PDD and DLB do not report different frequencies of VH by gender, although 
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it is important to consider the gender ratio in these disorders which are more common in men than 
women. 
Age risk factor and longitudinal course 
With regards to age as a risk factor for VH in psychosis, some studies have demonstrated evidence 
that VH are more common in younger, compared to older, individuals with schizophrenia
14, 16
, 
although negative findings exist
17
. A similar inconsistency is found in the eye disease literature with 
only 3 of 9 studies investigating age and visual hallucinations reporting a weak association
11
. 
By contrast, in non-clinical populations, the prevalence of VH is maximal in adolescence, and late 
adulthood, between which times the frequencies decrease
18, 19
. One explanation for increased 
frequency of VH with age is that the prevalence of most chronic disorders increases with age, as does 
the prevalence of neurodegenerative disorders and age-related eye disease. In further support, the 
prevalence of death-bed visions among the dying may be as high as 50% 
20
.  
Thus, there appears to be a bimodal distribution of VH in the population with one peak in late 
adolescence and early adulthood, which is associated with psychosis, and a second increase in late 
life associated with eye and brain disease. 
With regards to the longitudinal course, it is believed that hallucinations in schizophrenia tend to 
decrease as individuals age
21
, although it is important to note that the risk of schizophrenia also 
declines with age. 
Clinical characteristics of VH  
The presence of VH in psychosis has often been linked to more severe psychopathological profile
22, 
23
 and to a less favourable prognosis
24
. In patients with bipolar disorder, Baethge et al.
15
 found that 
hospitalisation for individuals with hallucinations (all modalities) averaged 17% longer than those 
who did not hallucinate. 
In the general community, a link between VH and anxiety (Odds Ratio = 5.0
25, 26
) and psychotic 
pathology (Odds Ratio = 6.6
25
) has been reported. The important role of negative emotions in VH is 
illustrated in studies showing that stress and bereavement are linked to VH. For example, 
hallucinations of a dead spouse are common grief reactions in older adults 
27
. 
The literature in neurodegenerative disease is consistent with this view of greater psychopathology in 
VH, with studies showing poorer response to treatment, greater mortality and morbidity, major 
depressive syndrome and a move to institutional care
28, 29
. 
Thus, in both younger patients with psychosis and older patients with neurodegenerative disease, VH 
are associated with poorer functioning and outcome. The same is not true of eye disease (e.g. CBS) 
where the symptoms improve over time without progressive loss of cognitive function. 
Association with other symptoms  
In schizophrenia, VH typically co-occur in association with other hallucinations and other sensory 
modalities
17, 22, 30, 31
. For example, it has been reported that co-occurring visual and auditory 
hallucinations occur in up to 84% of individuals with schizophrenia
22
. Furthermore, early evidence 
suggested VH never occurred in psychosis without the presence of auditory hallucinations (either at 
the same time – multimodality hallucinations - or on different occasions)31. In Oorschot et al.’s23 
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sample of individuals with mixed psychosis, VH occurring alone were rarer than auditory 
hallucinations occurring alone. As shown in Table 1, auditory hallucinations predominate over VH in 
terms of their relative prevalence. 
Hallucinations in multiple modalities have also been noted in individuals with severe depression
32
 
and with mixed psychiatric diagnoses
33
, as well as in non-clinical adults and adolescents (n = 355, 
11-13 years)
34
. Such co-occurrences of auditory/visual hallucinations suggest a common 
hallucinatory mechanism which, in combination with specific sensory dysfunctions, determines the 
modality of hallucinations.  
It is important to note however, that ‘simultaneous’ (or ‘fused’) auditory and visual hallucinations 
are not a frequent occurrence
17
. In most cases, they are experienced at different times (e.g. an 
auditory hallucination one day and a VH the next). Furthermore, when simultaneous auditory/visual 
hallucinations do occur, they are typically unrelated
35
 (e.g. seeing the devil while hearing the voice 
of a relative inside one’s head), suggesting that the mechanisms for auditory and visual 
hallucinations in these disorders must be partly independent, though with some overlap. 
By contrast, a different pattern can be observed in organic disease. In PD, VH predominate over 
auditory hallucinations
36
 and in CBS, the absence of hallucinations in other modalities is a diagnostic 
criterion. Where eye disease co-occurs with dementia, auditory hallucinations and delusions may 
appear as the dementia progresses in PD
37
, or dementia alone
38
. In these disorders, auditory and 
visual hallucinations very rarely occur at the same time. 
Overall, the relative proportion of auditory to visual modality hallucinations seems to differentiate 
the psychosis spectrum from organic conditions. 
4. Phenomenological features of VH  
Psychosis 
There are few systematic or comprehensive studies of VH as dimensional experiences in psychosis. 
Exceptions include Goodwin et al.
17
, Gauntlett & Kuipers
33
 and Dudley et al.
39
.  For the following 
review, information was drawn from these and other studies
14, 17, 30, 31, 40-42
.  
Perceptual qualities: VH in psychosis are reported to have the physical properties of real perceptions. 
They are often life-sized, detailed, solid. They are projected into the external world in most cases and 
are typically ‘anchored in external space’, either just beyond the reach of individuals, or further 
away. VH often have three dimensional shapes, with depth and shadows, and distinct edges. VH can 
be colourful or in black and white. Images are often described as dynamic with the contents changing 
in size, shape, and movement, but may also be static. 
Temporal aspects: The frequency of hallucinatory episodes varies from rare to frequent, and episodes 
can last several seconds to several minutes. VH may be experienced during both day and night. 
Content: Fully formed VH are more common than unformed visual experiences and distortions. 
Complex VH often comprise images of people (walking, family), faces, animals, objects, or events 
(e.g. visions of fires) taking place in front of the individual. In contrast to hallucinations in organic 
conditions, a common theme is of visions with frightening content (bugs, dogs, snakes, distorted 
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faces), and these are linked to distress. Unlike VH in PD, visions of dead people are rare, although 
visions of God, angels, the Devil, saints and fairies are common. 
Reality:  VH are perceived to be real and ‘definitely present’ in a concrete sense. In further support 
for the subjective reality of the experience, a majority of individuals undertake some activity directly 
related to the vision – such as moving towards the vision, hitting at the vision, or moving away. In 
the case of distressing images, individuals may act to keep themselves safe. 
Sense of control: A lack of control over the content and appearance is a prominent feature of VH in 
psychosis. Individuals are surprised when VH occur, and are generally helpless to change or stop 
them. In general, individuals believed that visions are experienced only by themselves. 
Onset and triggers: The onset of VH has been linked to stress, tiredness, loneliness and relationship 
problems in psychiatric individuals. Other psychological triggers include negative emotions, and 
they may co-vary with levels of anxiety. 
Reactions: A mixture of positive and negative images may be experienced. Reactions vary, and can 
include pleasure, happiness and reassurance, or indifference. Images can also evoke fright, 
depression, sadness or hopelessness.  While the content of VH is often impersonal or unrelated to the 
person, images are often interpreted to have personal implications. Many individuals believe that the 
content of visions must be acted upon, for fear of a negative event occurring as a consequence. This 
differs from hallucinations in organic conditions, where VH are not generally perceived to be real.  
Beliefs and appraisals: VH may be believed to arise from an external source, particularly of 
supernatural origin. Images of powerful religious figures are often perceived to be visions intended 
as a sign for the person to act and as a threat to their physical or psychological wellbeing. This can 
also impact on the individual’s belief system, and can be used as evidence for their delusional 
beliefs. 
Overall, such rich phenomenology of VH in psychosis points to true hallucinatory experiences and 
not only misperceptions. This close examination of VH characteristics also reveals remarkable 
similarities with auditory hallucinations with regards perceptual quality, contents, lack of control, 
beliefs, appraisals and reactions.  
With regards a comparison with organic disorders, broadly speaking, the form and character of VH 
in psychosis is similar to those seen in eye disease and neurodegeneration. Although there is a 
notable lack of studies making direct comparisons, there are several characteristics that distinguish 
VH in psychotic disorders from other disorders, namely frightening contents, emotional reactions 
and appraisals of personal significance; a lack of illusions (common in neurodegenerative disease) 
and simple visual hallucinations (common in eye disease) also differ. 
Subclinical symptoms in the general community 
Non-clinical individuals in the community report vivid VH, where objects are real and 
uncontrollable, but often of brief duration
43
. The features of VH in non-clinical samples are broad-
ranging and include unformed VH (such as dots, flashes of light and other unformed shapes) and 
formed VH (people and faces, but also aliens)
34
. In contrast to VH in psychosis, hallucinated images 
in non-clinical populations are less likely to involve complex scenes, but more likely to show people 
13
.   
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These VH clinical features are similar to that of auditory hallucinations in non-clinical populations, 
which also tend to be brief and mostly neutral or pleasant in content (see Johns et al, this issue). 
Eye-disease and neurodegenerative conditions  
For comparison with the above, the most detailed accounts of visual content are found in the eye-
disease literature (CBS)
44
. The commonest contents are of simple hallucinations, followed by images 
of people or animals (50-80%), patterns (55%), faces often described as grotesque and cartoon-like 
(40%), landscapes or inanimate objects (20%). They are usually colourful. Unlike in psychosis, VH 
in CBS are not generally perceived to be real, or to have personal meaning. Only in a third of the 
cases is the content negative. Once individuals understand they are a common feature of poor vision, 
anxiety about VH generally decreases. This differs from psychosis, where lack of insight may 
contribute to distress about these experiences. Other dimensional features related to clarity, 
frequency, temporal factors, and appearance, are similar to those in psychosis
45
. In PD, VH mostly 
consist of people who may be familiar or not, and alive or deceased (73%), animals (33%) and 
objects (19%) which may appear briefly and move sideways (passage hallucination) 
9
. The contents 
are fairly stereotyped and repetitive, but may last for hours at a time. Experiences appear to be real 
and outside voluntary control, but are not often perceived as frightening. In dementia, VH tend to be 
of fairly mundane content, including unfamiliar or small figures, faces, animals and 
objects/machines, and are rarely distressing
38
.  
Figure 1 (adapted from
46
) provides an overview of VH in different clinical settings, where a range of 
clinical conditions (columns) are cross-tabulated with VH content and related phenomena (rows).  
Comparing the phenomenology of VH in psychosis with other conditions suggests that they are most 
similar to VH in cortical and subcortical disorders (red box) but differ in the relative predominance 
of auditory and visual hallucinations. Whether this is an important neurobiological distinction is 
unclear and the boundary of the grouping has been left open as indicated by the dashed line.  
----Figure 1 ---- 
5. The assessment of visual hallucinations  
It is often difficult to distinguish VH from related visual phenomena such as illusions, distortions and 
misperceptions that co-occur with VH in psychosis and other conditions. The relationship between 
what is seen and what is actually present in the environment is complex and poorly understood with 
internal models and top-down inference interacting with visual inputs. The match between what is 
perceived and what is present is closest for veridical perception (our day-to-day visual perceptual 
experience), tenuous for illusions and absent for hallucinations; however, there are no sharp dividing 
lines between categories. Based on a working definition of hallucinations
47
 the key features to elicit 
in an assessment of VH are (see Box text 1): 
1. They must be experienced in full consciousness (rules out sleep-related VH, fever, delirium, 
and hypnosis) 
2. Not elicited by an external stimulus (excludes visual distortions and illusions) 
10 
 
3. The experience has a sense of reality to resemble a veridical perception (must have physical 
properties of real perceptions and be located in external space); (note that this does not mean 
that VH must be perceived to be real, or that insight must be lacking) 
4. The subject does not feel s/he has direct and voluntary control (rules out visual imagery) 
---Box Text 1 --- 
6. Cognition 
Cognitive processes of VH in psychosis have rarely been investigated. In organic disorders, 
hallucinations are held to reflect disorders within distributed perceptual systems. The Perceptual 
and Attentional Deficit model (PAD) advocates for a combination of impaired visual processing 
and attention in VH in neurodegenerative disorders and eye disease
48. Diederich et al.’s49 
contemporaneous PD-developed interactive model similarly proposes a combination of poor visual 
input and processing with defective central visual monitoring. More recently, Shine et al.’s 
Attentional model
50
 proposes that hallucinations occur in PD when there is underactivity in dorsal 
attentional networks in the presence of ambiguous percepts. Each of these models, therefore, 
proposes that combined attentional and visual perceptual problems lead to VH. 
In psychosis, however, perceptual processes are usually believed to be intact or even overactive. It 
has been suggested that VH in psychosis may be best understood in terms of the intrusion into 
awareness of subconscious images or highly vivid mental imagery, as modulated by personal, 
social or psychological variables
26
. In support, an increase in the salience of imagery has been 
found in schizophrenia individuals with VH
51
. Other cognitive deficits found in psychotic VH 
include source-monitoring impairments, such as difficulties making internal/external and self/other 
discriminations
52
 and confusion regarding whether the source of material was real or imagined
53
. 
Such source-monitoring deficits are also commonly found in auditory hallucinations
54
 and may lead 
to these events being believed as real.  
Personal, social and cultural contributors to VH have not yet been systematically investigated, 
although top-down mechanisms (which include expectations, personal meaning-making, and social 
context) may influence dynamic attentional processes by biasing the competition between potential 
perceptions towards objects and persons that have personal and social relevance. In support for this 
view, stress and bereavement are linked to the onset of VH. Further support comes from cognitive 
models of psychosis
47
 that propose that key influences of personal events, social/cultural context 
and expectations have the ability to activate percepts in the absence of external stimulation.  
Altogether, mechanisms of VH in psychosis are not well understood. Interesting similarities with 
the literature on auditory hallucination exist, including source monitoring deficits and the strong 
influence top-down mechanisms. By contrast, evidence for visual processing difficulties which 
feature strongly in models of VH in the organic literature
46
 is lacking. 
7. Brain imaging and electrophysiology 
In the field of psychosis, a study conducted in individuals with first episode psychosis (n =15 with 
VH) showed per-hallucinatory activity within visual association cortex, while the vividness of VH 
was linked to activity within primary visual cortex
55
. Activity in the visual association cortex 
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during VH has also been demonstrated in single case studies in schizophrenia
56, 57
. Concerning the 
organic literature, dysfunctions of higher visual processing areas during or between VH episodes 
have been found in AD
58
, DLB
59, 60
 and CBS
61
 within the ventral and the dorsal visual pathways 
involved in object recognition and visuo-spatial memory
62, 63
 as well as the frontal lobes
64
. 
Furthermore, structural changes in these areas were independent of cognitive function and age
65
. 
Overall, symptom-capture studies in these populations showed that the location of the per-VH 
activity correlated with the phenomenological content of the hallucinatory experiences (i.e. colour 
specialised cortex if in colour, face-specialised cortex if faces are experienced, etc). 
Connectivity studies have much relevance for the study of VH, given that dysconnectivity is a 
prominent model for psychosis, which could also apply to specific symptoms such as 
hallucinations
66
. The dysconnectivity hypothesis suggests that the existence of impaired 
connectivity between different brain regions is responsible for abnormal functional integration 
within neural networks. In support for dysconnectivity, using diffusion tensor imaging (DTI), 
Ashtari and collaborators showed that adolescents suffering from early-onset schizophrenia with a 
history of VH exhibited lower fractional anisotropy, potentially reflecting a loss in white-matter 
integrity, in the left inferior longitudinal fasciculus which connects temporal and occipital cortices, 
when compared with individuals without VH
67
. 
The hippocampal complex (HC) is also of considerable interest with regards to VH in both 
neurodegeneration and psychosis. The HC has been shown to be atrophied in individuals with PD 
and VH
68
, and it appears to occupy a key place within the networks involved in VH in psychosis
69
. 
For example, a recent multimodal connectivity study, combining functional connectivity, tract-
based spatial statistics and shape analysis of the HC confirmed differential connectivity patterns of 
this structure in individuals with schizophrenia. Moreover, this abnormal connectivity depends on 
the sensory-modality of hallucinatory experiences involved, and was particularly obvious with 
visual areas in patients with VH
66
. In addition, a symptom capture study of VH in schizophrenia
56
 
reported cortical activity in the hippocampal complex, although this was not reported in CBS
61
. 
A particular sub-type of functional connectivity studies focuses on spontaneous fluctuations at rest. 
It has already been used in the field of auditory hallucinations to test the hypothesis of disrupted 
intrinsic connectivity as a pathological mechanism
70
. Jardri and colleagues’ study confirmed a 
dynamic interaction between association sensory cortices and the default-mode network (DMN) for 
patients with multisensory hallucinations, including VH
55
. Sensory and DMN networks were found 
to be anti-correlated during the experience of hallucinations; furthermore the DMN spatial and 
temporal instability persisted during non-hallucinatory periods
55
. Impaired interactions with the 
DMN have also been suggested in the pathophysiology of VH in PD
50
, but contrary to what has 
been proposed in first-episode psychosis in which the DMN seems primarily and intrinsically 
affected, these authors proposed an external DMN interference through aberrant interactions with 
ventral and dorsal attentional networks.  
Fewer studies have investigated the electrophysiology of VH. Spencer and colleagues found 
reduced visual cortical activation (evoked NI component) and increased gamma band phase locking 
associated with VH in schizophrenia, consistent with an underlying visual cortical hyperexcitability 
and reduced responsiveness to external visual stimulation in this subgroup
71
. Indices of 
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hyperexcitability and reduced responsiveness have also been found in PD (delayed P100)
72
 and 
post-LSD VH (occipital theta coherence)
73
 .The electrophysiology of VH capture is consistent with 
brain imaging studies in suggesting activation of visual association cortex as measured by 
coherence
74
 or theta/alpha desynchronisation
75
. 
8. Comparative psychopathology 
What are the implications of the similarities and differences between VH in psychosis spectrum, 
eye and neurodegenerative disease outlined above? It is clear that there is an absence of evidence in 
many areas, and that direct comparative work is required. VH in psychosis most closely resemble 
VH in neurodegeneration, and the association of auditory and visual hallucinations in these 
conditions suggests the two modalities of hallucination share a common pathophysiological 
mechanism. Dysfunctions in attentional and executive/top-down mechanisms are also common in 
both neurodegenerative and psychotic conditions, as are occipital cortex and hippocampal complex 
involvement during hallucinations.  
However, the differing predominance of auditory and visual modalities in neurodegenerative 
disease and psychosis, the phenomenological differences at the levels of emotional reactions and 
appraisals, and the differing dysconnectivity and visual processing profiles suggest there are also 
important differences. Perhaps the same pathological mechanism has differential effects on the 
visual and auditory systems in psychosis and neurodegenerative disease, depending on the 
presence/absence of specific co-occurring sensory dysfunctions. Such comparative insights have 
potentially important implications for treating VH as they provide a rationale for importing 
approaches found effective in one clinical context to another. 
9. Treatment approaches 
Cognitive behavioural therapy  
Cognitive Behavioural Therapy has an established, though modest, evidence base for the 
treatment of psychosis (referred to as CBTp). However, evidence for its use in VH rests mainly 
on case studies. 
Recently, O’Brien & Johns76 described an individual who had visions of snakes and who held 
beliefs that he was at risk of harm from these snakes. CBT that included a graded exposure 
approach to help reduce fear and escape reaction showed some benefit which was maintained at 
three months. Whether this is helpful with other visual experiences is unclear, although studies 
show that the appraisals and beliefs should be a core target for treatment
39, 77
. 
Collerton and Dudley
78
 developed a model drawn from a cognitive model of auditory 
hallucinations and panic and which targets appraisal and reactions to VH. Given that avoidance, 
escape and safety-seeking behaviours are common but unhelpful strategies, the aim of treatment 
is for people to recognise that they are safe, and that the fear may be real but the danger is not. 
The therapy includes psycho-education about VH, reality testing and normalisation, as well as 
understanding of triggers. Imagery exposure and transformation strategies are used to attempt 
control over the experience. A case series (under review) describes the use of this treatment 
approach in four people with psychosis with distressing VH.  
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Overall, evidence for the effectiveness of CBT for VH is limited. The treatment of VH may be 
improved by addressing trauma and stress as a key feature of VH presentation, and with the 
development of sensitive and specific outcome measures that match the goals of treatment. 
The pharmacological management of VH  
There is limited evidence for specific pharmacological treatments for VH in psychosis. 
Antipsychotics are typically used but some studies have reported that VH were not linked to 
treatment effects
30, 79
, or even that VH may be a marker of neuroleptic resistance 
80
. Clozapine has 
been reported as effective for VH in PD
81
 but studies in schizophrenia are lacking. 
The literature drawn from organic disease suggests that different approaches that might be 
considered. For example, for individuals with visual impairment, treatment of the eye condition can 
reduce the risk of VH
82
. The case report literature has highlighted a range of medications that may 
help reduce VH but there is currently a lack of clinical trial data. For example, drugs increasing 
cholinergic activity are thought to reduce the risk for VH. The AchE-I (rivastigmine, donepezil and 
galantamine) are beneficial when treating behavioural and psychological symptoms of dementia 
83
 
and PD
84
 and have been reported to help in schizophrenia
84
. Other drugs have been used in organic 
conditions (antidepressants, memantine or anticonvulsants), but have not been examined in 
psychosis. 
In sum, there is a lack of systematic studies but this overview suggests new possibilities for treating 
VH in psychosis. 
10. Conclusion 
Altogether, this paper reviewed the available evidence on the prevalence, phenomenology, clinical 
characteristics, assessment methods, cognition, brain imaging, electrophysiology, and treatment 
approaches for VH in the psychosis spectrum.  
There are significant potential benefits to making direct comparisons of VH in organic and 
psychotic illness. These include informing our understanding and theoretical models of VH in 
schizophrenia and across diagnostic categories, informing hypothesis-driven questions for research, 
and suggesting new possibilities for therapeutic interventions. 
This is the first review of VH in psychosis to incorporate data using different methodological 
perspectives and different population groups. One open question is whether VH in psychosis have 
the same pathological mechanisms as VH in eye or organic conditions. From the evidence, it is 
clear that they are not as closely associated as they might appear. They show some similarities in 
clinical presentation and form, and in cognitive mechanisms, but differences in age, emotional 
content and appraisal, pathological profile, and neuroimaging findings might argue for different 
causal pathways. There is also little evidence one way or the other on whether visual perception in 
psychosis is as impaired as it is in other disorders. 
This review also aided our understanding of hallucinations across different modalities, and 
particularly auditory hallucinations. As seen above, auditory hallucinations and VH frequently co-
occur, although not necessarily simultaneously. One possibility suggests a set of core pathological 
mechanisms in addition to specific modality-dependent dysfunctions. Alternatively, the same 
pathological mechanism has differential effects on the visual and auditory systems in psychosis and 
14 
 
neurodegenerative disease, depending on the presence/absence of specific co-occurring sensory 
dysfunctions. Clearly, direct comparisons are needed testing the compatibility of theoretical models 
developed in the two modalities of hallucinations (see key future directions, in Table 4).  
 
---- Table 4 here --- 
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Table 1. The comparative point prevalence of visual and auditory hallucinations in schizophrenia 
Authors  n Modality of hallucinations 
   Visual  Auditory  
Bowman & Raymond (1931) 
12
  1408 22% 53% 
Arnold (1949) in 
5
 * 14% 78% 
Feinberg (1962) 
85
 19 4% 84% 
Malitz, Wilkens, Esecover (1962) 
86
 100 9% 50% 
Vitols, Waters, Keeler (1963) 
87
 110 13% 35% 
Goldberg, Klerman, Cole 
80
 270 18% 45% 
Mott, Iver, Anderson (1965) 
88
 50 24% 66% 
Small, Small, Anderson (1966) 
42
 50 30% 66% 
Chapman (1966) 
89
 * 40% * 
Holmboe  & Astrup (1967) 
90
 255 25% 79% 
Jansson (1968) 
91
 293 13% 25% 
Goodwin, Alderson, Rosenthal (1971) 
17
 45 59% 82% 
Eggers (1973) 
92
 * 44% 71% 
McCabe (1976) 
24
  40 20% 36% 
Young (1974) 
93
 20 45% * 
Zarroug (1975) 
94
 69 47% 62% 
Ciompi & Müller (1976) 
95
  * 18% 58% 
McCabe (1976) 
24
 25 20% 52% 
Deiker, Chambers (1978) 
96
 28 64% 86% 
Huber (1979) 
97
 * 33% 75% 
Ndetei, Singh (1983) 
98
 51 43% 43% 
Ndetei (1984) 
99
 141 15% 41% 
Winokur et al. (1985) 
100
 140 32% 78% 
Phillipson & Harris (1985) 
101
 73 62% 44% 
Bracha, Wolkowitz et al. (1989) 
30
 43 56% 42% 
Owens & Slade (1989) 
102
 * 29% 63% 
Mueser et al. (1990) 
22
 117 14% 71% 
Jablensky et al. (1992) 
4
 1288 30% 55% 
Bauer et al. (2011) 
16
 
  
1238 
 
34% 79% 
 
Total: 29 studies 5,873  
 
Weighted Mean 
= 27% 
SD = 9.73 
Weighted Mean = 
59% 
SD = 15.30 
* not assessed or missing data 
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Table 2. The comparative prevalence of visual hallucinations and auditory hallucinations in bipolar and 
affective disorder  
 
Authors n Diagnosis  Modality of hallucinations 
      Visual  Auditory  
Bowman & Raymond (1931) 
12
  1009 Mania  9% 17% 
Rosenthal et al. (1966) 
103
  79 Mania 21% 30% 
Winokur (1969) 
100
 100 Mania 9% 21% 
Goodwin, Alderson & Rosenthal 
(1971) 
17
 
28 Primary affective 
disorder 
72% 82% 
Taylor & Abrams (1975) 
104
 52 Mania 23% 47% 
Rosenthal et al. (1980) 
105
 32 Mania 25% 30% 
Winokur (1984) 
106
 122 Bipolar disorder 9% 14% 
Black & Nasrallah (1989) 
107
 467 Acute bipolar disorder 6% 13% 
Mueser et al. (1990) 
22
  bipolar disorder 25% 75% 
  37 Severe affective 
disorder   
10% 17% 
Keck et al. (2003) 
108
 352 Mania 22% 25% 
Baethge et al. (2005) 
15
 33 Manic/mixed type 
with hallucinations 
27% 54% 
  32 Depressed type with 
hallucinations 
25% 59% 
Tillman et al. (2008) 
109
  549 BPD 26% 57% 
Total: 12 studies                    Sum: 2,892  Weighted 
mean = 15% 
SD = 9.75 
Weighted 
mean: 28% 
SD = 18.11 
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Table 3. The comparative prevalence of visual hallucinations and auditory hallucinations in the general 
community (A), and after excluding hallucinations arising from drug taking or physical illness (B) 
  
(A) General population 
 
 n Visual Hallucinations 
Eaton et al. (1991)
110
      810  8%   
Tien (1991)
18
 18,572 14%   
Ohayon (2000)
25
 13,057  3.2%   
Waters et al. (2003)
111
     562 (university students) 10%    
Larøi & Van der Linden (2005)
112
 
Kessler et al. (2005)
113
 
    236 (university students) 
 9,282 
32% 
 6.3%  
 
Total: 6 studies Sum: 42,519 Weighted Mean = 7.35%  
SD = 5.08 
 
 
(B) Excl drug taking and physical illness 
 
   
 n Visual Hallucinations 
Eaton et al. (1991)
110
  810 4%  
Tien (1991)
18
 18,572 7%  
Van Os et al. (2000)
51
  7,076 2-6%  
 Sum: 26,458 Weighted Mean = 6%  
SD: 1.73 
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Figure 1: Visual perceptual symptoms and their clinical contexts 
46
 
 
 
 
A range of clinical conditions (columns) are cross-tabulated with visual hallucination content and related 
phenomena (rows). For each condition, the percentage of individuals  with visual hallucinations reporting a 
given content is coded red (> 20%), pink (10% - 20%) or white (not reported or < 10%). The prevalence of 
each symptom in psychosis is taken from 
33
. For auditory hallucinations, + indicates higher prevalence than 
VH and – indicates lower prevalence than VH. (Figure adapted from ffytche 2007). Visual experiences in 
schizophrenia best match the phenomena reported in the red box derived from PD, AD, DLB and peduncular 
lesions – but not the green (eye and visual pathway pathology) and blue (serotonergic syndrome) boxes.   
 
. 
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Box text 1. A diagnostic algorithm for visual hallucinations and related phenomena
114
 
Question 1: Are the visual phenomena experienced (a) during sleep, (b) on the border of waking and 
sleeping, or (c) while awake? 
During sleep     → Rule out: dream 
→ Possibility 1: incubus phenomenon 
→ Possibility 2: visual sleep start 
On the border of waking and sleeping → Possibility 1: hypnagogic hallucination 
     → Possibility 2: hypnopompic hallucination 
While awake    → Continue with Question 2 
 
Question 2: Are the visual phenomena perceptual in nature? (i.e. with physical properties of real 
perceptions) 
No → Rule out: imagery 
Yes → Continue with Question 3 
 
Question 3: Do they constitute (a) images without a representation in the outside world, (b) images 
with a representation in the outside world, or (c) distortions? 
Images without a representation in the outside world (visual hallucinations) → Continue with Question 4 
Images with a representation in the outside world (visual illusions) → Continue with Question 5 
Distortions (metamorphopsias) → Continue with Question 6 
 
Question 4: Are the hallucinations (a) simple in nature, (b) geometric, (c) complex, or (d) compound 
(i.e., multimodal) in nature? 
Simple hallucinations:  → Rule out: Physiological phenomena such as blue-field entoptic 
phenomenon, macular star pattern or mouches volantes (uncomplicated) 
    → Determine: type and context 
Geometric hallucinations: → Determine: type and context 
Complex hallucinations: → Determine: type and context 
Compound hallucinations:  → Determine: type (i.e., sensory modalities) and context 
 
Question 5: Are the illusions attributable to (a) physical reality, (b) the perceptual system, or (c) 
mental associations? 
Physical illusions: (e.g. mirage)               → Determine: type and context (never pathological!) 
Physiological illusions (e.g. afterimage)  → Determine: type and context 
Cognitive illusions: (e.g. Necker cube)    → Determine: type and context 
 
Question 6: Do the distortions have (a) a peripheral or (b) a central origin? 
Peripheral metamorphopsias: → Determine: type and context 
Central metamorphopsias: → Determine: type and context  
20 
 
 
Table 4: Future directions 
 
Future studies should seek to pursue the following research questions: 
i) What is the frequency of VH in psychosis, as assessed using prospective, rigorous and detailed 
investigations? What is the relationship of VH with hallucinations in other modalities (e.g. temporal 
relationship, similarities in content and emotional themes)? 
ii) Are ‘fused’ multimodality hallucinations characteristic of schizophrenia, or do they occur in other 
disorders? Is there a close relationship between VH and voices in fused hallucinations, such that 
there is a match between the vision and the verbal output? Is the acoustic information closely linked to 
the speaker’s characteristics (sex, age, emotional characteristics)? Are there reports of fused 
hallucinations of animals (e.g. dogs barking), and environmental scenes (e.g. car with engine running, 
water falls), in addition to fused hallucinations of persons (person talking)?  
iii) What are the similarities and differences in the VH profile of individuals with psychosis compared to 
other psychiatric/neurological conditions at the level of phenomenological characteristics, risk factors, 
triggers, cognition, psychology, social and brain factors, as assessed using direct comparisons?   
iv) Are the same brain regions and networks activated during VH in psychosis also activated during VH in 
other conditions? Are the changes in brain structure, function and connectivity predisposing to VH the 
same across different conditions? 
v) What are the mechanisms involved in hallucinations in different modalities? Is there a set of core 
pathological mechanisms in addition to specific modality-dependent dysfunctions? Alternatively, is 
there one pathological mechanism that has differential effects on visual and auditory systems? 
vi) What is the compatibility of verbal (language based) models of auditory hallucinations which focus on 
deviations in language areas, with models of visual hallucinations? 
vii) What are the mechanisms by which distress and negative mood contribute to both visual and auditory 
hallucinations? 
viii) What is the predictive value of non-clinical VH (especially for those first observed in 
childhood/adolescence), as assessed using longitudinal epidemiological study designs? 
ix) Are there different subtypes of VH, and which type is most often associated with poorer prognosis and 
functioning? 
x) Research into the treatment for VH in individuals requiring care is urgently needed, examining the 
efficacy of existing and new interventions in large samples 
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